Indaptus Therapeutics(INDP) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Indaptus Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update NEW YORK (November 12, 2024) - Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company"), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announced financial results for the third quarter ended September 30, 2024, and provided a corporate update. Jeffrey Meckler, Indaptus Therapeutics' Chief Executive Officer, comm ...